Global Precision Psychiatry Market was valued at USD 1.0 Billion in 2022 and is projected to reach USD 2.7 Billion by 2030, growing at a CAGR of 15.0% from 2024 to 2030.
The Global precision psychiatry market is experiencing robust growth, driven by advancements in genomics, neuroimaging, and data analytics. Precision psychiatry aims to tailor mental health treatments to individual biological, environmental, and lifestyle factors, leading to improved diagnostic accuracy and treatment efficacy. As mental health conditions become increasingly prevalent worldwide, demand for personalized care is rising, pushing both public and private sectors to invest in innovative psychiatric solutions. Integration of artificial intelligence and machine learning into clinical workflows is enhancing predictive modeling, patient stratification, and early intervention strategies. The market is further propelled by rising awareness, supportive healthcare policies, and increasing research funding for neuropsychiatric conditions. In particular, North America holds a significant share due to its advanced healthcare infrastructure, while Asia-Pacific is emerging rapidly due to expanding mental health initiatives and growing biotech industries. The overall market outlook remains highly positive, with compound annual growth expected to continue over the coming years.
The expanding scope of biomarkers and pharmacogenomics is opening new frontiers in precision psychiatry, offering the potential to match patients with the most effective therapies based on their genetic and molecular profiles. This shift toward individualized medicine is driving the development of new diagnostic tools and therapeutics, particularly for complex disorders such as schizophrenia, bipolar disorder, and major depression. Telepsychiatry and digital therapeutics are also gaining traction, providing accessible and scalable mental health solutions that align with personalized treatment models. Regulatory support and partnerships between academic institutions and industry players are fostering innovation and accelerating the commercialization of precision-based psychiatric interventions. Despite challenges such as high costs and ethical concerns regarding data privacy, the long-term benefits of reducing trial-and-error prescribing and improving patient outcomes are incentivizing sustained investment. As technology continues to evolve, the precision psychiatry market is poised to become a cornerstone of modern mental health care, reshaping the way psychiatric disorders are understood and treated.
Get an In-Depth Research Analysis of the Gloabl Precision Psychiatry Market Size And Forecast [2025-2032]
llumina
Inc
F. Hoffmann-La Roche Ltd.
Bio-Rad Laboratories
Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
ARUP Laboratories
Invitae Corporation
OPKO Health
Inc.
Laboratory Corporation of America Holdings
Centogene N.V.
Thermo Fisher Scientific Inc.
Myriad Genetics
Inc.
Konica Minolta
Inc.
Fulgent Genetics
PreventionGenetics
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Gloabl Precision Psychiatry Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Gloabl Precision Psychiatry Market
Genetic Testing
Biomarker Analysis
Brain Imaging Techniques
Wearable Devices
Artificial Intelligence and Machine Learning Solutions
Depression
Anxiety Disorders
Bipolar Disorder
Schizophrenia
Post-Traumatic Stress Disorder (PTSD)
Clinics
Hospitals
Research Institutes
Pharmaceutical Companies
Home Care Settings
In-person Consultations
Telepsychiatry
Mobile Health Platforms
Remote Monitoring Services
Adults
Pediatric
Elderly
Pregnant Women
Veterans and Active Military Personnel
US (Global, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Precision Psychiatry Market Research Analysis
1. Introduction of the Gloabl Precision Psychiatry Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Gloabl Precision Psychiatry Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Gloabl Precision Psychiatry Market, By Type
6. Gloabl Precision Psychiatry Market, By Application
7. Gloabl Precision Psychiatry Market, By Geography
North America
Europe
Asia Pacific
Rest of the World
8. Gloabl Precision Psychiatry Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/